Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Dopamine Hydrochloride Injection in shortage?

Yes. Dopamine Hydrochloride Injection is on FDA’s drug shortage list (unavailable), last updated Oct 2, 2026.

In shortageFDA status
11packages listed
3unavailable

Why it’s in shortage

  • Demand increase for the drug
  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)
    Baxter HealthcareIn shortageAvailableUpdated Oct 2, 2026

    Maker contact: 888-229-0001

  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)
    Baxter HealthcareIn shortageAvailableUpdated Oct 2, 2026

    Maker contact: 888-229-0001

  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)
    Baxter HealthcareIn shortageAvailableUpdated Oct 2, 2026

    Maker contact: 888-229-0001

  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)
    Baxter HealthcareIn shortageAvailableUpdated Oct 2, 2026

    Maker contact: 888-229-0001

  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Sep 22, 2026

    Maker contact: 844-646-4398

  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Sep 22, 2026

    Maker contact: 844-646-4398

  • Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Sep 22, 2026

    Maker contact: 844-646-4398

  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Sep 22, 2026

    Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Sep 22, 2026

    Maker contact: 844-646-4398

  • Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Sep 18, 2026

    Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe.

    Maker contact: 800-631-2174

  • Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Sep 18, 2026

    Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released.

    Maker contact: 800-631-2174

FDA recalls of Dopamine Hydrochloride

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Dopamine Hydrochloride Injection:

Dopamine Hydrochloride Injection shortage questions

Is Dopamine Hydrochloride Injection in shortage?

Yes. Dopamine Hydrochloride Injection is on FDA’s drug shortage list (unavailable), last updated Oct 2, 2026.

Why is there a Dopamine Hydrochloride Injection shortage?

FDA records the reason as: Demand increase for the drug; Other.

What should I do if I can’t get Dopamine Hydrochloride Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.